AIFG Consultants »

Regeneron Pharmaceuticals shares owned by AIFG Consultants

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by AIFG Consultants from 13F filings

Historical chart of AIFG Consultants investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by AIFG Consultants consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by AIFG Consultants

Quarter filed Position value Share count Share price at filing
2024-03-31 $428k 444 964.36
2023-12-31 $388k 442 877.65
2023-09-30 $365k 439 831.85

More positions owned by AIFG Consultants

Spdr Portfolio S&p 1500 Composite Stock Market Etf Etf (SPTM)
Spdr Portfolio Aggregate Bond Etf Etf (SPAB)
First Trust Nasdaq-100 Equal Weighted Index Fund Etf (QQEW)
Jpmorgan Equity Premium Income Fund Jpmorgan Equity Premium Income Fund Etf (JEPI)
Ft Vest Us Equity Moderate Buffer Etf February Etf (GFEB)
Spdr Portfolio Developed World Ex-us Etf Etf (SPDW)
Spdr Gold Minishares Trust Etf (GLDM)
Spdr Portfolio S&p 500 Growth Etf Etf (SPYG)
Ft Vest U.s. Equity Buffer Etf - July Etf (FJUL)
Invesco Bulletshares 2026 High Yield Corp Bond Etf Etf (BSJQ)
First Trust Smid Cap Rising Dividend Achievers Etf Etf (SDVY)
First Trust Morningstar Dividend Leaders Index Fund Etf (FDL)
Ft Vest U.s. Equity Enhance & Moderate Buffer Etf - March Etf (XMAR)
Ishares National Muni Bond Etf Etf (MUB)
Ft Cboe Vest Fund Of Buffer Etfs Etf (BUFR)

View all positions for AIFG Consultants

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
Jpmorgan Chase & Co
Dodge & Cox
Wellington Management Company
Norges Bank Investment Management
Legal & General Group
Bank of America Corporation
Amundi
Bank of New York Mellon
Citadel Advisors
Alliancebernstein
T. Rowe Price Associates
Susquehanna International
Ubs Global Asset Management Americas
Charles Schwab Investment Management

View all funds holding Regeneron Pharmaceuticals